HIMS

Hims & Hers Health, Inc.NYSEHealthcare

$19.14-3.53%OpenMarket Cap: $4.20B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-27	TD Cowen	—	Hold	—
2026-03-16	Leerink Partners	—	Market Perform	—
2026-03-11	Barclays	—	Overweight	—
2026-03-10	Deutsche Bank	—	Hold	—
2026-03-10	B of A Securities	—	Neutral	—
2026-03-10	Citigroup	—	Neutral	—
2026-03-09	Needham	—	Buy	—
2026-02-25	Morgan Stanley	—	Equal Weight	—
2026-02-24	Evercore ISI Group	—	In Line	—
2026-02-24	TD Cowen	—	Hold	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.58	$3.31B	9
Sun Dec 31	$1.08	$3.92B	5
Mon Dec 31	$1.38	$4.73B	1
Tue Dec 31	$1.86	$4.63B	1